Amantadine-induced cortical myoclonus

Neurology

Volumn 56, Issue 2, 2001, Pages 279-280

  Matsunaga, Kauoru ^a   Uozumi, T ^a   Qingrui, L ^a   Hashimoto, T ^a   Tsuji, S ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ATENOLOL; CARBIDOPA; FAMOTIDINE; LEVODOPA; LEVOTHYROXINE; PRAZOSIN; TICLOPIDINE;

AGED; ARTICLE; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; ELECTROMYOGRAM; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; KIDNEY DISEASE; MOTOR DYSFUNCTION; MYOCLONUS; PATHOGENESIS; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

EID: 0035936627     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.2.279     Document Type: Article

References (7)

1. Drug-induced movement disorders
2. Amantadine-induced "vocal" myoclonus
3. Negative myoclonus in Creutzfeldt-Jakob disease
4. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy
5. Clinical pharmacokinetics of amantadine hydrochloride
6. Focal cortical transient preceding myoclonus during lithium and tricyclic antidepressant therapy
7. Twenty-five years of amantadine therapy in Parkinson's disease